How many US stocks are undervalued right now?

As of 2026-08-28, 1,268 of the 3,809 US equities CirclFi can currently value (33.3%) trade below the median fair value of their active models, and 2,540 (66.7%) trade above it. For the median US equity, that median fair value sits 23.4% below the current share price. CirclFi covers 5,875 US equities in total; 3,809 of them have enough filing history for at least two of the 13 models to return a usable fair value, which is the denominator here. Every figure is recomputed after each US market close.

What is a good Quality of Company (QOC) score?

CirclFi's QOC score runs 0–10 across 32 fundamental signals in four pillars: profitability, growth, stability and capital efficiency. A score of 7 or above marks the top tier. 55 of 5,875 US equities currently score 9.5 or higher. This directory is sorted by QOC, so the highest-quality companies appear first.

Which high-quality US stock is currently undervalued?

The highest-quality US stock currently trading below CirclFi's 13-model median fair value is Gilead Sciences, Inc. (GILD), which scores 9.7/10 on quality against a median fair value of $152.03 — 4.4% above its current share price of $145.68 as of 2026-08-28. Quality and cheapness rarely coincide: only 1,268 of 3,809 rated companies trade below their median at all.

Is CirclFi's stock valuation data free?

Yes. The quality score, current price, 13-model median fair value and implied upside for all 5,875 US equities are free to browse, with no account required. Every valuation is derived from SEC EDGAR XBRL filings and recomputed after each US market close. A paid tier adds the full per-model breakdown and the screener.

How often are CirclFi's stock valuations updated?

Every valuation on this page is recomputed after each US market close, using the latest SEC EDGAR filings, market prices and FRED macroeconomic series. This page was last rebuilt on 2026-08-28.

5,875 Equities Tracked · Quality 8.4–8.5/10

US Stocks Rated 8.4–8.5 out of 10 for Quality

The 100 US equities scoring 8.4–8.5 on CirclFi's Quality of Company score, each with its 13-model median fair value and implied upside. Recomputed after every US market close.

1,268 of the 3,809 US equities CirclFi can currently value (33.3%) trade below the median fair value of their active models as of 2026-08-28, and 2,540 (66.7%) trade above it. For the median US equity that fair value sits 23.4% below the current share price, and 55 companies score 9.5 or higher for fundamental quality. The highest-quality name currently trading at a discount is Gilead Sciences, Inc. (GILD), at 9.7/10 quality with a $152.03 median fair value, 4.4% above its $145.68 price.

Two counts appear on this page. CirclFi publishes a page for all 5,875 US equities it covers, and 3,809 of those have enough filing history for at least two of the 13 models to return a usable fair value. Only that second group can be called undervalued or overvalued, so it is the denominator above; the remaining 2,066 are recent listings, shell companies and issuers with incomplete XBRL, and they are reported as unvalued rather than counted as fairly valued.